Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LP-PRP in Chondromalacia Patella
NCT06020794Completed
- Sponsor
- Kayseri City Hospital
- Start
- Feb 2021
- Primary completion
- Aug 2022
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of Leukocyte-Poor Platelet Rich Plasma in chondromalacia patella (2 arms), sponsored by Kayseri City Hospital. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 12 weeks. Started Feb 2021; status: completed.
02
Drugs
Leukocyte-Poor Platelet Rich Plasma
03
Conditions
chondromalacia patella
Beyond the preview
Go deeper on NCT06020794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06020794.